Meta-analysis: treating anemia with erythropoietin-stimulating agents does not seem to improve health-related quality of life for patients with chronic Kidney Disease 19 Feb, 2016 | 19:04h | UTC The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease: A Systematic Review and Meta-analysis – Annals of Internal Medicine (link to abstract – subscription required for full text)